BRESHECK (BRESEK) Syndrome

BRESHECK (also written BRESEK) is a very rare genetic condition seen mostly in boys. It affects many parts of the body from birth. The name is an acronym that describes the common problems:

• Brain anomalies (brain structure differences)

• Retardation (older term; today we say intellectual disability)

• Ectodermal dysplasia (skin, hair, nails, teeth, sweat glands form abnormally)

• Skeletal deformities (bones and spine form differently)

• Hirschsprung disease (missing nerve cells in the bowel) — present in some patients

• Ear/eye anomalies (hearing and vision issues)

• Cleft palate or cryptorchidism (undescended testes) — in some patients

• Kidney dysplasia/hypoplasia (kidneys small or poorly formed)

BRESHECK is a very rare, mostly X-linked condition that affects many body systems from birth. The name is an acronym for the main features: Brain anomalies, Retardation (intellectual disability) and growth delay, Ectodermal problems (skin, hair, teeth, sweat glands), Skeletal malformations, Hirschsprung disease (a bowel nerve problem causing severe constipation), Ear/eye anomalies, Cleft palate or cryptorchidism, and Kidney dysplasia or hypoplasia. Many reported cases also overlap with IFAP syndrome (ichthyosis follicularis, atrichia, photophobia). Recent reports identify mutations in MBTPS2, a gene important for cholesterol handling and cell stress responses, as a cause of the IFAP/BRESHECK spectrum. Because it is so rare, care focuses on early diagnosis, structured monitoring, and treatment of each feature. onlinelibrary.wiley.com+3PubMed+3NCBI+3

Not every person has all parts of the acronym. The core pattern “BRESEK” lists the most typical features (Brain, intellectual disability, Ectodermal, Skeletal, Ear/eye, Kidney). When the extra findings like Hirschsprung disease and cleft palate are present, doctors sometimes use “BRESHECK.” PubMed+2Pediatric Neurology Briefs+2

Most cases known so far are linked to changes (variants) in a gene called MBTPS2 on the X chromosome. This gene helps cells manage cholesterol processing and stress inside the endoplasmic reticulum (ER). When MBTPS2 does not work properly, many tissues—especially skin, hair, nerves, ears, eyes, kidneys, and bones—may develop abnormally before birth. onlinelibrary.wiley.com+2PubMed+2

BRESHECK shares biology with a related X-linked disorder called IFAP (Ichthyosis Follicularis, Atrichia, Photophobia). Some MBTPS2 variants cause “IFAP only,” while others cause the broader, more severe IFAP/BRESHECK picture with multiple congenital anomalies and intellectual disability. NCBI+1

Other names

• BRESEK syndrome (Brain anomalies, severe intellectual disability, Ectodermal dysplasia, Skeletal deformities, Ear/eye anomalies, Kidney dysplasia) rarediseases.info.nih.gov+1

• BRESHECK syndrome (BRESEK features plus Hirschsprung disease and/or cleft palate/cryptorchidism) PubMed

• IFAP/BRESHECK syndrome (IFAP with additional malformations) NCBI

• MBTPS2-related ectodermal dysplasia with multiple anomalies (descriptive, gene-based name) onlinelibrary.wiley.com

• X-linked mental retardation, Reish type (historic paper describing early families) onlinelibrary.wiley.com

Types

Because this is rare, there is no single official “type” list. Clinicians often group patients in practical ways:

1. By genetic cause (MBTPS2 variant class).
   Some mutations change one amino acid; others cause bigger gene disruptions. Certain variants are linked to a more severe, multi-system BRESHECK picture; others to “IFAP-predominant” disease. Genetic reports describe expanding phenotypes with different MBTPS2 changes. sciencedirect.com+1

2. By clinical spectrum (IFAP → BRESEK → BRESHECK).
   Think of a spectrum from IFAP (skin/hair/eye triad) to BRESEK (adds brain/ear/eye/kidney/bone) to BRESHECK (adds Hirschsprung or cleft/cryptorchidism). Pediatric Neurology Briefs+1

3. By organ-system dominance.
   Some children mainly have skin/hair problems; others have major kidney, brain, or gut involvement. Doctors plan care around the organs most affected. Summary descriptions from major databases highlight this multi-system variability. NCBI+1

Causes

The single root cause is genetic: pathogenic variants in MBTPS2 on the X chromosome. Everything below ties back to this gene not working correctly. To match your requested “20 causes,” I list 20 closely related mechanisms and contributors that explain how one gene change leads to many body changes. (Clinically, MBTPS2 mutation is the cause.) onlinelibrary.wiley.com+1

1. MBTPS2 loss-of-function. The gene encodes “site-2 protease,” needed to activate certain transcription factors; when it fails, development goes off track. disorders.eyes.arizona.edu

2. Disrupted cholesterol homeostasis. Cells cannot process sterols normally, which alters cell membranes and signaling in developing organs. disorders.eyes.arizona.edu

3. Impaired ER-stress response. Cells cannot handle protein-folding stress well, damaging tissues that grow quickly in the fetus. disorders.eyes.arizona.edu

4. Abnormal epidermal differentiation. Skin, hair, nails, sweat glands (ectoderm) form poorly—classic ectodermal dysplasia biology. NCBI

5. Neurodevelopmental vulnerability. Brain cells rely on sterol signaling; disturbances can yield brain malformations and intellectual disability. (Inference consistent with syndrome description and MBTPS2 role.) NCBI+1

6. Inner ear development disturbance. Ears depend on precise embryologic steps; ectodermal/bone changes can cause hearing loss. (Syndrome feature lists document ear anomalies.) NCBI

7. Ocular surface and optic nerve effects. IFAP causes eye surface problems and photophobia; BRESHECK may add small optic nerves. rarediseases.info.nih.gov

8. Skeletal patterning effects. Vertebrae, ribs, and digits may form abnormally (scoliosis, polydactyly). NCBI

9. Renal morphogenesis defects. Sterol/ER-stress pathways are important in kidney branching; kidneys may be small or dysplastic. NCBI

10. Enteric nervous system development. Some patients develop Hirschsprung disease (missing bowel nerves), showing neural crest involvement. PubMed

11. Craniofacial development disturbance. Cleft palate can occur when midline fusion is altered. PubMed

12. Gonadal/testicular descent interference. Cryptorchidism sometimes appears; broad developmental signaling disruption likely contributes. PubMed

13. Variant-specific severity. Some MBTPS2 mutations are “hotspots” for severe multisystem disease. sciencedirect.com

14. X-linked inheritance. Boys (one X chromosome) are usually affected; carrier females may be unaffected or mildly affected depending on X-inactivation. (General X-linked principle; MBTPS2 is X-linked.) NCBI

15. De novo mutation. A new MBTPS2 change can arise in a family with no history. (Observed across MBTPS2-related conditions.) onlinelibrary.wiley.com

16. Possible contiguous gene effects. Early papers noted the idea of a nearby deletion modifying severity. (Hypothesis from initial families.) PubMed

17. Maternal mosaicism (rare). A mother with mosaic MBTPS2 mutation can have more than one affected son. (Considered in early reports.) PubMed

18. Modifier genes/environment (theoretical). Differences in other pathways may shape severity, as suggested by wide variability. (Inference consistent with phenotype spread.) NCBI

19. Prenatal growth stress. Tissues growing fast (skin, brain, kidney) are more sensitive to ER-stress and sterol pathway problems. (Mechanistic inference from MBTPS2 function.) disorders.eyes.arizona.edu

20. Shared pathway with IFAP. The overlap explains why some families show IFAP, others BRESHECK, under the same gene. NCBI

Symptoms and signs

Symptoms differ from child to child. These are commonly reported features with a short explanation:

1. Developmental delay and intellectual disability. Learning and daily living skills are slower to develop due to brain differences. NCBI

2. Structural brain differences. For example, thin corpus callosum or enlarged ventricles; may link to seizures or motor delay. NCBI

3. Seizures (some children). Abnormal electrical activity in the brain can cause convulsions or staring spells. (Case descriptions include seizures.) thejns.org

4. Ectodermal dysplasia skin changes. Dry, rough, spiky follicular bumps (ichthyosis-like) and decreased sweating. NCBI

5. Absent or sparse scalp hair (atrichia). Hair may be very thin or missing from early infancy. NCBI

6. Light sensitivity (photophobia). Bright light hurts the eyes due to corneal surface problems. NCBI

7. Nail and tooth differences. Nails may be thin or brittle; teeth may be missing or shaped differently. (General ED features.) NCBI

8. Ear anomalies and hearing loss. Ears may be low-set or large; hearing can be reduced. rarediseases.info.nih.gov

9. Eye anomalies. Optic nerves can be small; other eye structure issues may occur. NCBI

10. Scoliosis or vertebral anomalies. The spine can curve or vertebrae can have unusual shapes. NCBI

11. Extra digits (polydactyly) in some. One or more extra fingers or toes may be present. NCBI

12. Kidney dysplasia/hypoplasia. Kidneys may be small, asymmetrical, or poorly formed, sometimes causing reduced function. NCBI

13. Feeding difficulties/failure to thrive. Poor weight gain can occur, sometimes with reflux or oral-motor challenges. (Seen in case series.) thejns.org

14. Hirschsprung disease (some). Severe constipation from missing bowel nerve cells; may need surgery. PubMed

15. Cleft palate or cryptorchidism (some). A split in the roof of the mouth and/or undescended testes. PubMed

Diagnostic tests

Goal: confirm the diagnosis, map which organs are affected, and guide care. Because it is very rare, testing is personalized.

A) Physical examination

1. Full dysmorphology exam. A geneticist checks face, skull, ears, limbs, skin, hair, nails, teeth, and genitalia to match the BRESHECK pattern. NCBI

2. Skin and hair assessment. Doctors look for follicular bumps, dryness, reduced sweating, and sparse/absent hair typical of IFAP/BRESHECK. NCBI

3. Neurologic exam. Muscle tone, reflexes, coordination, and seizure history are reviewed to gauge brain involvement. NCBI

4. Spine/limb exam. Screening for scoliosis, vertebral step-offs, rib or digit anomalies (e.g., polydactyly). NCBI

5. Growth and development check. Head size, weight/height trends, and developmental milestones provide a severity snapshot. Pediatric Neurology Briefs

B) “Manual” bedside tests

6. Hearing screening (otoacoustic emissions). A quick bedside test to pick up inner ear function problems early. (Common first-line for syndromic hearing loss.) rarediseases.info.nih.gov

7. Vision screening and photophobia challenge. Gentle light testing to confirm light sensitivity and need for tinted lenses. (IFAP hallmark.) NCBI

8. Dental inspection. Counting teeth and checking enamel helps document ectodermal dysplasia impact. NCBI

9. Bowel function evaluation (rectal exam). Helps detect severe constipation that could suggest Hirschsprung disease. PubMed

10. Scoliosis forward-bend test. A simple check for spinal curvature guiding need for imaging. NCBI

C) Laboratory & pathological tests

11. Genetic testing: MBTPS2 sequencing and deletion/duplication analysis. This is the confirmatory test for diagnosis; test the child first, then consider the mother (carrier check). onlinelibrary.wiley.com+1

12. Skin biopsy (selected cases). If needed, pathology can show follicular hyperkeratosis or other ED changes; not always required if genetics is clear. (ED/IFAP context.) NCBI

13. Renal function labs. Creatinine, cystatin C, urinalysis to monitor kidney health when dysplasia is present. (Standard in renal anomalies.) NCBI

14. Electrolytes and hydration profile. Children with reduced sweat or feeding issues may have salt/water imbalance; labs guide support. (ED physiology.) NCBI

15. Rectal suction biopsy (if Hirschsprung suspected). Pathology looks for missing ganglion cells to confirm Hirschsprung disease. PubMed

D) Electrodiagnostic tests

16. Brain EEG. If seizures or spells occur, EEG can show abnormal brain rhythms and guide anti-seizure therapy. (Reported in case care.) thejns.org

17. Auditory brainstem response (ABR). If bedside hearing screen is abnormal, ABR quantifies hearing loss for early hearing aids. (Syndromic hearing loss workflow.) rarediseases.info.nih.gov

E) Imaging tests

18. Brain MRI. Maps structural differences (e.g., thin corpus callosum, ventricular enlargement) and helps evaluate seizures or delay. NCBI

19. Spine X-ray or MRI. Checks scoliosis, vertebral anomalies, and spinal cord status when indicated. NCBI

20. Renal ultrasound (and follow-up scans). Looks for small kidneys or dysplasia; repeated over time to monitor growth and function. NCBI

Non-pharmacological treatments (therapies & other care)

1. Genetic counseling & family planning.
   Purpose: explain inheritance, recurrence risk, and testing options for relatives.
   Mechanism: a genetics professional reviews clinical features, confirms suspected X-linked patterns, orders MBTPS2 testing if appropriate, and builds a surveillance plan for organs commonly involved (brain, bowel, hearing, kidneys). This reduces uncertainty, guides future pregnancies, and coordinates subspecialists. PubMed+1

2. Early intervention program (0–5 years).
   Purpose: maximize development during the most plastic period of the brain.
   Mechanism: coordinated physical, occupational, and speech therapy based on standardized assessments; parent coaching for home exercises; assistive seating and safe mobility training for hypotonia or skeletal issues. Early, repetitive practice strengthens neural pathways that support communication, feeding, motor skills, and self-care.

3. Physical therapy (PT).
   Purpose: improve strength, posture, balance, and mobility; reduce contractures and scoliosis risk.
   Mechanism: graded stretching, core stabilization, joint protection, and gait training. PT adapts positions to protect hips/spine and uses orthoses or walkers when needed to keep alignment and conserve energy.

4. Occupational therapy (OT).
   Purpose: build daily-living skills (feeding, dressing, toileting) and fine motor control.
   Mechanism: task-specific practice, sensory strategies for touch- or light-sensitivity, adaptive utensils and writing tools, and splints to prevent hand deformities.

5. Speech-language therapy & feeding therapy.
   Purpose: support speech, language comprehension, and safe swallowing.
   Mechanism: oral-motor exercises, language stimulation routines, and texture modification to prevent aspiration. Augmentative-alternative communication (AAC) may be introduced early to give a voice even before speech is reliable.

6. Bowel management program for Hirschsprung/constipation.
   Purpose: keep the colon empty, prevent enterocolitis, and reduce hospital visits.
   Mechanism: surgeon-guided rectal irrigations or enemas, scheduled toileting, fluid/fiber coaching, and toileting posture. After pull-through surgery, nurses teach home routines to avoid fecal stasis. UTHSC

7. Hearing support (audiology).
   Purpose: detect hearing loss early and fit amplification.
   Mechanism: newborn/periodic hearing tests, ear-molded hearing aids or bone-anchored devices, and classroom accommodations (FM systems). Early sound access drives language pathways in the brain.

8. Low-vision & eye-protection strategies.
   Purpose: optimize remaining vision and protect sensitive eyes (photophobia).
   Mechanism: tinted lenses, brimmed hats, high-contrast materials, task lighting, and scheduled ophthalmology checks. For dry eye or exposure risk, frequent lubrication and blink training help protect the cornea. disorders.eyes.arizona.edu

9. Dermatologic skin care routine.
   Purpose: reduce scaling, itch, and skin infections in ectodermal dysplasia/ichthyosis.
   Mechanism: daily lukewarm bathing, gentle cleansers, thick emollients within 3 minutes of bathing (“soak and seal”), careful keratolytic use (under dermatology guidance), and nail/follicle hygiene to reduce impetigo risk. disorders.eyes.arizona.edu

10. Dental and craniofacial care.
    Purpose: manage enamel defects, bite problems, and cleft-related feeding/speech issues.
    Mechanism: early dental home, fluoride varnish, sealants, orthodontic planning, and team-based cleft palate pathway (speech therapy, palatal obturators pre-repair, and coordinated surgery/timing).

11. Nutrition optimization.
    Purpose: support steady growth and wound healing and prevent constipation.
    Mechanism: dietitian-led assessment of calories, protein, fiber, and fluids; consideration of high-calorie formulas or gastrostomy in severe feeding problems; and reflux-minimizing meals (small, frequent, upright positioning).

12. Respiratory hygiene & infection prevention.
    Purpose: lower risk from aspiration and recurrent ear/sinus infections.
    Mechanism: airway clearance routines, safe-swallow plan, vaccination on schedule, caregiver hand-hygiene, and prompt evaluation of fevers.

13. Orthotics & adaptive equipment.
    Purpose: improve alignment and function for foot, knee, or spinal issues.
    Mechanism: AFOs (ankle-foot orthoses), thoracolumbosacral braces for scoliosis, supportive seating, standing frames, and custom footwear to distribute pressure and reduce fatigue.

14. Educational supports (IEP/504).
    Purpose: ensure access to learning.
    Mechanism: formal evaluations and written plans for speech/hearing/vision supports, extended time, seating, note-taking aids, AAC access, and one-to-one paraprofessional support if needed.

15. Behavioral and family mental-health support.
    Purpose: help with frustration, sleep, or anxiety and prevent caregiver burnout.
    Mechanism: parent-coaching, routines, positive-behavior supports, and counseling; respite services and local rare-disease peer groups.

16. Social work & care coordination.
    Purpose: navigate referrals, durable medical equipment, and home services.
    Mechanism: a coordinator organizes appointments, tracks surveillance (kidney, spine, hearing), and connects families to benefits and transportation.

17. Sun/heat safety education.
    Purpose: protect skin and prevent overheating if sweating is reduced.
    Mechanism: light clothing, shade, regular fluids, fans/misters, and broad-spectrum sunscreen re-applied every 2 hours.

18. Hydration & fiber coaching.
    Purpose: prevent constipation and urinary tract infections.
    Mechanism: daily fluid goals by weight/age, soluble fiber foods, and scheduled toileting. Combine with bowel program if Hirschsprung features are present. UTHSC

19. Renal surveillance plan.
    Purpose: protect kidney function and detect scarring early.
    Mechanism: periodic ultrasound, urinalysis, and blood pressure checks; prompt treatment of UTIs; nephrology input for dysplasia/hypoplasia. NCBI

20. Multidisciplinary clinic follow-up.
    Purpose: keep every system on one roadmap.
    Mechanism: shared care plans across pediatrics, genetics, neurology, ENT, ophthalmology, dermatology, surgery/urology, nephrology, GI, rehab, and mental health, with regular intervals tailored to age and phenotype. NCBI

---

Drug treatments

Important: These medicines treat specific symptoms (constipation, seizures, infections, reflux, allergy, cytopenias, thyroid issues, etc.). Doses and timing are examples from FDA labels for their approved uses, not BRESHECK-specific approvals. Your clinician will individualize dose, schedule, and monitoring, or choose non-drug options first.

1. Polyethylene glycol 3350 (PEG; MiraLAX®)
   Class: osmotic laxative. Typical dose: label-based adult 17 g once daily; pediatric dosing per clinician.
   Purpose & mechanism: draws water into stool to relieve constipation, useful before/after Hirschsprung surgery under guidance. Side effects: bloating, cramps. FDA label/approval package. FDA Access Data+3FDA Access Data+3FDA Access Data+3

2. Lactitol (Pizensy®)
   Class: osmotic laxative. Adult dose often 20 g once daily (adjust per response).
   Purpose & mechanism: retains water in colon to soften stool and promote bowel movements. Side effects: gas, diarrhea. FDA label. FDA Access Data

3. Levetiracetam (Keppra®)
   Class: antiepileptic. Pediatric/adult dosing varies by weight/indication.
   Purpose & mechanism: reduces neuronal hyperexcitability (SV2A binding). Side effects: somnolence, behavioral changes; monitoring needed. FDA label. FDA Access Data+1

4. Nitrofurantoin (Macrobid®/Macrodantin®/Furadantin®)
   Class: urinary antibacterial. Typical: Macrobid 100 mg twice daily for acute cystitis (adult label).
   Purpose & mechanism: concentrates in urine to treat susceptible lower UTIs; protects kidneys by early treatment of infections. Side effects: GI upset; rare pulmonary/hepatic reactions. FDA labels. FDA Access Data+2FDA Access Data+2

5. Amoxicillin (± clavulanate)
   Class: β-lactam antibiotic. Pediatric doses per label/weight.
   Purpose & mechanism: first-line for many ear/sinus infections; clavulanate expands spectrum when β-lactamase organisms suspected. Side effects: diarrhea, rash. FDA labels. FDA Access Data+1

6. Metronidazole (Flagyl®/ER; Likmez®)
   Class: nitroimidazole antibiotic. Dosing varies by infection.
   Purpose & mechanism: active against anaerobes—sometimes used in Hirschsprung-associated enterocolitis protocols under surgical guidance. Side effects: metallic taste, GI upset; avoid alcohol. FDA labels. FDA Access Data+2FDA Access Data+2

7. Ofloxacin otic (Floxin® Otic)
   Class: fluoroquinolone ear drops. Typical: label dosing course for otitis externa/media with perforation.
   Purpose & mechanism: topical bactericidal levels in ear; useful when ear anatomy is abnormal. Side effects: local irritation. FDA label. FDA Access Data

8. Ofloxacin ophthalmic (Ocuflox®)
   Class: fluoroquinolone eye drops. Dosing per label.
   Purpose & mechanism: treats susceptible bacterial conjunctivitis/keratitis, protecting vision when eyelids/ocular surface are affected. Side effects: transient burning. FDA label. FDA Access Data

9. Triamcinolone acetonide cream (various strengths)
   Class: topical corticosteroid. Apply thin layer 1–3×/day per label and dermatologist advice.
   Purpose & mechanism: reduces inflammation/itch in eczematous flares in ectodermal skin. Side effects: skin thinning with overuse—use lowest effective potency. FDA labeling. FDA Access Data+1

10. Cetirizine (Zyrtec®)
    Class: oral H1-antihistamine. Typical: 5–10 mg daily (adult label); pediatric weight-based.
    Purpose & mechanism: blocks histamine to reduce itch/urticaria that worsens skin picking and sleep. Side effects: drowsiness in some. FDA label. FDA Access Data

11. Omeprazole (Prilosec®)
    Class: proton-pump inhibitor. Dosing varies by age/indication.
    Purpose & mechanism: decreases gastric acid for reflux that can aggravate feeding and aspiration risk. Side effects: headache, diarrhea. FDA label. FDA Access Data+1

12. Levo-thyroxine (Synthroid®/Levo-T®)
    Class: thyroid hormone. Dose individualized by TSH/FT4.
    Purpose & mechanism: replaces deficient thyroid hormone if hypothyroidism is present, supporting growth and development. Side effects: overtreatment causes tachycardia, irritability, weight loss. FDA labels. FDA Access Data+1

13. Filgrastim (Neupogen®) or biosimilars
    Class: G-CSF leukocyte growth factor. Doses vary by indication.
    Purpose & mechanism: boosts neutrophils in clinically significant neutropenia (not routine; use if indicated, e.g., cytopenias reported in some cases). Side effects: bone pain; rare splenic issues. FDA labels. FDA Access Data+1

14. Epoetin alfa (Procrit®/Epogen®)
    Class: erythropoiesis-stimulating agent. Dosing per label and cause of anemia.
    Purpose & mechanism: stimulates red blood cell production when clearly indicated; monitor Hb closely. Side effects: hypertension, thrombotic risk. FDA labels. FDA Access Data+1

15. Erythromycin topical (acne/folliculitis management)
    Class: topical antibiotic. Apply per label.
    Purpose & mechanism: reduces bacterial load in inflamed follicles that can complicate ectodermal skin. Side effects: local dryness/irritation. FDA labeling. FDA Access Data+1

16. Lubricant eye preparations (example: antibiotic ointment when indicated)
    Class: ophthalmic preparations.
    Purpose & mechanism: protect cornea in exposure/dryness; antibiotic ointments used only when infected. Specific drug/dose per ophthalmologist and label. (General note with FDA context for ophthalmic antibiotics.) FDA Access Data

17. Analgesics/antipyretics (as directed)
    Class: acetaminophen/ibuprofen (OTC labels).
    Purpose & mechanism: comfort after procedures (e.g., cleft or pull-through surgery), reduce fever. Use weight-based dosing and surgeon’s plan. (Label-directed use; check pediatric dosing).

18. Sodium chloride nasal irrigation/sprays
    Class: non-drug devices/OTC.
    Purpose & mechanism: reduce crusting, improve nasal airflow when facial anomalies or cleft repair cause dryness; supports sleep and feeding.

19. Topical urea or lactic acid keratolytics
    Class: OTC dermatologic keratolytics.
    Purpose & mechanism: soften scale and improve skin flexibility; avoid overuse and follow dermatology instructions.

20. Prophylaxis biologic for RSV in eligible infants (palivizumab)
    Class: monoclonal antibody. Dose/season per label and guidelines when eligibility is met.
    Purpose & mechanism: reduces severe RSV hospitalizations in high-risk infants; consider if significant lung/airway vulnerability. Side effects: injection-site reactions. FDA label. FDA Access Data+1

Safety note: These medicines are for the listed, label-approved conditions. In BRESHECK, doctors may use them off-label to manage overlapping problems. Always individualize to kidney function, age, procedures, and interactions.

---

Dietary molecular supplements

(Evidence for supplements in BRESHECK specifically is limited; use only with clinician/dietitian oversight, especially with kidney issues. NIH ODS fact sheets support general roles/dosing ranges.)

1. Vitamin D3 — supports bone strength and immune function; typical maintenance ranges (e.g., 600–1000 IU/day in many children, higher if deficient) are individualized to blood 25-OH D. Helps calcium absorption and may aid growth and fracture prevention when levels are low. Monitor to avoid toxicity. Office of Dietary Supplements

2. Omega-3 fatty acids (EPA/DHA) — doses vary; often 250–1000 mg/day combined EPA+DHA in older children/adults (diet first). May support skin barrier and reduce inflammation; choose purified products to minimize reflux and fishy aftertaste. Office of Dietary Supplements

3. Zinc — typical supplement amounts 5–20 mg/day depending on age/status. Zinc supports wound healing, taste, and immune function; excess can lower copper. Monitor levels if used long-term. Office of Dietary Supplements

4. Biotin — age-based adequate intakes (e.g., 30 µg/day for most adults) support keratin structure for hair/skin/nails; mega-doses can distort lab tests (e.g., thyroid assays). Office of Dietary Supplements

5. Probiotics — strain-specific products may support stool regularity post-surgery; discuss with GI, especially if immunocompromised.

6. Prebiotic fiber (inulin/partially hydrolyzed guar gum) — increases stool bulk and softens stool; start low to limit gas.

7. Iron (only if deficient) — individualized elemental iron dosing (e.g., 2–6 mg/kg/day in children with iron-deficiency anemia) under lab monitoring to protect kidneys and avoid constipation.

8. Calcium — meet daily needs through food first; supplement only if intake is low, particularly when vitamin D is corrected.

9. Magnesium — gentle osmotic effect can support bowel programs; discuss dosing to avoid diarrhea and electrolyte shifts.

10. Multivitamin (age-appropriate) — fills small dietary gaps while specialized diets are tried; avoid duplicates of fat-soluble vitamins.

(Vitamin D, Omega-3, Zinc, Biotin background: NIH Office of Dietary Supplements.) Office of Dietary Supplements+3Office of Dietary Supplements+3Office of Dietary Supplements+3

---

Immunity-booster / regenerative / stem-cell–type” drugs

There are no FDA-approved stem-cell drugs for BRESHECK syndrome. In select, clearly indicated situations, clinicians may use the following supportive biologics based on standard indications—not because of BRESHECK itself.

1. Intravenous immunoglobulin (IVIG) — for proven primary antibody deficiency (hypogammaglobulinemia), dosing and frequency per immunology; reduces serious infections by replacing antibodies. (Use an FDA-approved IVIG product per label for PIDD; example labels vary by brand.)

2. Filgrastim (G-CSF) — boosts neutrophils when clinically indicated cytopenias occur; shortens neutropenia duration and lowers febrile infection risk. FDA Access Data

3. Epoetin alfa — increases red-cell production in specific anemias; careful hemoglobin targets and thrombotic risk counseling. FDA Access Data

4. Palivizumab — seasonal RSV prevention for eligible high-risk infants; reduces RSV hospitalizations. FDA Access Data

5. Nutritional rehabilitation (medical nutrition therapy) — while not a drug, restoring calories/protein/micronutrients improves immune resilience and wound healing; often the most “regenerative” step.

6. Hematopoietic stem-cell transplant (HSCT) — not standard for BRESHECK; may be considered only if a severe marrow failure phenotype is definitively present and a transplant team recommends it after risk-benefit review (case-by-case).

---

Surgeries (procedure & why done)

1. Pull-through surgery for Hirschsprung disease.
   Removes the aganglionic bowel segment and connects healthy colon to the anus to allow stool passage, preventing life-threatening enterocolitis and chronic megacolon. UTHSC

2. Cleft palate repair.
   Closes the palatal gap to improve feeding, speech, and reduce ear infections by restoring eustachian tube function; coordinated with speech therapy and ENT.

3. Orchiopexy.
   Fixes undescended testes in the scrotum to preserve fertility potential and lower torsion/cancer risks.

4. Ventriculoperitoneal (VP) shunt (when hydrocephalus present).
   Diverts cerebrospinal fluid from brain ventricles to the abdomen to relieve pressure and protect brain tissue.

5. Scoliosis or limb deformity correction.
   Uses bracing or surgical rods/osteotomies to straighten and stabilize the spine/limbs, improving sitting balance, lung capacity, and comfort.

---

Preventions (everyday protection)

1. Stay up to date on vaccinations per age/eligibility (ask about RSV prophylaxis if eligible). FDA Access Data

2. Hand-washing and prompt care for fevers to reduce severe infections.

3. Daily bowel program to prevent fecal stasis and enterocolitis after Hirschsprung surgery. UTHSC

4. Adequate fluids/fiber to protect bowel and bladder.

5. Skin “soak and seal,” fragrance-free products, and nail hygiene to avoid secondary infections. disorders.eyes.arizona.edu

6. Sun/heat safety and breathable clothing to prevent overheating.

7. Scheduled hearing/vision checks to catch changes early.

8. Renal ultrasound/urinalysis monitoring plan to protect kidneys. NCBI

9. Safe-swallow plan and reflux control to lower aspiration risk.

10. Home safety review (bath seats, rails, seizure-safe sleeping guidance if seizures are present).

---

When to see a doctor urgently

• Persistent vomiting, swollen abdomen, fever, or explosive diarrhea (possible enterocolitis) after Hirschsprung surgery. UTHSC

• New seizures, severe headache, vomiting, or vision change.

• Signs of UTI (painful urination, fever, flank pain) or poor urine output, especially with kidney anomalies. NCBI

• Rapidly worsening rash, spreading redness, or fever with skin lesions (possible cellulitis).

• Failure to gain weight, dehydration, or aspiration signs during feeding.

• Any sudden behavior change, high fever, or breathing difficulty.

---

What to eat and what to avoid

• Eat: soft, moist foods that are easy to chew and swallow; small frequent meals if reflux.

• Eat: fiber-rich fruits/vegetables/whole grains as tolerated to keep stool soft.

• Eat: adequate protein (eggs, dairy, beans, fish or alternatives) for growth and wound healing.

• Eat: healthy fats (olive oil, avocado); consider omega-3 foods (fatty fish) weekly. Office of Dietary Supplements

• Eat: plenty of water across the day; use straw or sips between bites for kids with oral motor fatigue.

• Avoid (or limit): very spicy, acidic, or greasy foods that can worsen reflux.

• Avoid: highly constipating foods (very low-fiber snack foods) if bowel slows.

• Avoid: known personal allergens; keep an antihistamine plan if prescribed. FDA Access Data

• Avoid: dehydration in heat; pack water and salty snacks if sweating is reduced.

• Avoid: uncooked high-risk foods if the child is immunocompromised; follow food-safety hygiene.

---

Frequently Asked Questions

1. Is BRESHECK the same as IFAP?
   They overlap. IFAP (ichthyosis follicularis, atrichia, photophobia) and BRESHECK share features; both have been linked to MBTPS2 variants, with BRESHECK describing a broader malformation pattern. rarediseases.org+1

2. What gene is involved?
   Several reports identify MBTPS2 variants in the IFAP/BRESHECK spectrum; earlier work discussed X-linked patterns before the gene was known. PubMed+1

3. How is it diagnosed?
   By a clinical geneticist using exam findings, imaging, and targeted genetic testing (often panels that include X-linked genes and/or MBTPS2). NCBI

4. Is there a cure?
   No single cure; care is feature-specific and supportive, often with excellent gains from early therapies and surgeries.

5. What’s the outlook?
   Outcome varies by brain, bowel, kidney, and infection severity. Early, continuous supports improve function and quality of life.

6. Can girls be affected?
   Yes, but usually more mildly due to X-inactivation; severity varies. X-linked inheritance counseling is important. PubMed

7. Is Hirschsprung disease always present?
   No. It’s part of the BRESHECK spectrum but not universal; when present, surgical pull-through is standard. UTHSC

8. What about school?
   Children can thrive with IEP/504 supports, AAC if needed, and audiology/vision accommodations.

9. Do we need regular kidney checks?
   Yes—ultrasound and urine/blood pressure monitoring are common to protect renal function. NCBI

10. Is skin care medical or cosmetic?
    Medical. Consistent emollients, gentle keratolytics, and infection prevention reduce pain, itch, and hospital visits. disorders.eyes.arizona.edu

11. Are there BRESHECK-specific medicines?
    No. Medicines are chosen to treat each problem (constipation, seizures, infections, reflux, allergy, cytopenias, etc.) and are label-approved for those problems, not for BRESHECK itself. (See drug section for FDA labels.) FDA Access Data+2FDA Access Data+2

12. Should we use supplements?
    Only to correct deficiencies or support a clinician-approved goal. Use NIH ODS fact sheets and lab monitoring. Office of Dietary Supplements+1

13. Who coordinates care?
    A primary pediatrician with a clinical geneticist and a care coordinator; regular multidisciplinary clinics help.

14. Can we plan future pregnancies?
    Yes. Genetic counseling explains carrier testing, options, and prenatal/early postnatal planning. PubMed

15. Where can I learn more?
    Medical genetics databases and rare-disease organizations summarizing BRESHECK/IFAP features and ongoing research. NCBI+1

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: November 02, 2025.